» Articles » PMID: 14722616

Bone Marrow-derived Progenitor Cells in Pulmonary Fibrosis

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2004 Jan 15
PMID 14722616
Citations 291
Authors
Affiliations
Soon will be listed here.
Abstract

The origin of fibroblasts in pulmonary fibrosis is assumed to be intrapulmonary, but their extrapulmonary origin and especially derivation from bone marrow (BM) progenitor cells has not been ruled out. To examine this possibility directly, adult mice were durably engrafted with BM isolated from transgenic mice expressing enhanced GFP. Induction of pulmonary fibrosis in such chimera mice by endotracheal bleomycin (BLM) injection caused large numbers of GFP(+) cells to appear in active fibrotic lesions, while only a few GFP(+) cells could be identified in control lungs. Flow-cytometric analysis of lung cells confirmed the BLM-induced increase in GFP(+) cells in chimera mice and revealed a significant increase in GFP(+) cells that also express type I collagen. GFP(+) lung fibroblasts isolated from chimera mice expressed collagen and telomerase reverse transcriptase but not alpha-smooth muscle actin. Treatment of isolated GFP(+) fibroblasts with TGF-beta failed to induce myofibroblast differentiation. Cultured lung fibroblasts expressed the chemokine receptors CXCR4 and CCR7 and responded chemotactically to their cognate ligands, stromal cell-derived factor-1 alpha and secondary lymphoid chemokine, respectively. Thus the collagen-producing lung fibroblasts in pulmonary fibrosis can also be derived from BM progenitor cells.

Citing Articles

The Chemokine System as a Key Regulator of Pulmonary Fibrosis: Converging Pathways in Human Idiopathic Pulmonary Fibrosis (IPF) and the Bleomycin-Induced Lung Fibrosis Model in Mice.

Russo R, Ryffel B Cells. 2025; 13(24).

PMID: 39768150 PMC: 11674266. DOI: 10.3390/cells13242058.


Prostatic Escherichia coli infection drives CCR2-dependent recruitment of fibrocytes and collagen production.

Scharpf B, Ruetten H, Sandhu J, Wegner K, Chandrashekar S, Fox O Dis Model Mech. 2025; 18(1).

PMID: 39748675 PMC: 11789281. DOI: 10.1242/dmm.052012.


Targeting Fibrosis: From Molecular Mechanisms to Advanced Therapies.

Di X, Li Y, Wei J, Li T, Liao B Adv Sci (Weinh). 2024; 12(3):e2410416.

PMID: 39665319 PMC: 11744640. DOI: 10.1002/advs.202410416.


Fibrocytes in tumor microenvironment: Identification of their fraction and novel therapeutic strategy.

Mitsuhashi A, Nishioka Y Cancer Sci. 2024; 116(1):21-28.

PMID: 39492802 PMC: 11711040. DOI: 10.1111/cas.16385.


Transformation of macrophages into myofibroblasts in fibrosis-related diseases: emerging biological concepts and potential mechanism.

Li X, Liu Y, Tang Y, Xia Z Front Immunol. 2024; 15:1474688.

PMID: 39386212 PMC: 11461261. DOI: 10.3389/fimmu.2024.1474688.


References
1.
Grove J, Lutzko C, Priller J, Henegariu O, Theise N, Kohn D . Marrow-derived cells as vehicles for delivery of gene therapy to pulmonary epithelium. Am J Respir Cell Mol Biol. 2002; 27(6):645-51. DOI: 10.1165/rcmb.2002-0056RC. View

2.
Ahmed F, Wyckoff J, Lin E, Wang W, Wang Y, Hennighausen L . GFP expression in the mammary gland for imaging of mammary tumor cells in transgenic mice. Cancer Res. 2002; 62(24):7166-9. View

3.
Huaux F, Liu T, McGarry B, Ullenbruch M, Phan S . Dual roles of IL-4 in lung injury and fibrosis. J Immunol. 2003; 170(4):2083-92. DOI: 10.4049/jimmunol.170.4.2083. View

4.
Crystal R, Bitterman P, Rennard S, HANCE A, Keogh B . Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts). N Engl J Med. 1984; 310(3):154-66. DOI: 10.1056/NEJM198401193100304. View

5.
Clark J, Hansen J, Hertz M, Parkman R, Jensen L, Peavy H . NHLBI workshop summary. Idiopathic pneumonia syndrome after bone marrow transplantation. Am Rev Respir Dis. 1993; 147(6 Pt 1):1601-6. DOI: 10.1164/ajrccm/147.6_Pt_1.1601. View